Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma

J Adv Pract Oncol. 2014 May;5(3):211-5.

Author

Suzanne McGettigan¹

Affiliation

¹ Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.

PMID: 25089220
PMCID: PMC4114496

No abstract available

Publication types

Review